Tower Research Capital »

Seres Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.0k 794 8.87
2025-06-30 $2.1k 185 11.11

More positions owned by Tower Research Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shares Etf Trust Daily Semiconduc (SOXL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Inc Cap Stk Cl A (GOOGL)
Ishares Tr Core Us Aggbd Et (AGG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vaneck Etf Trust Pharmaceutcl Etf (PPH)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)

View all positions for Tower Research Capital

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Capital Management
Susquehanna International
Marshall Wace
Vontobel Holding
BlackRock
Geode Capital Management
American Century Companies
Citadel Advisors
Vanguard Fiduciary Trust
State Street Corporation
Charles Schwab Investment Management
Lion Point Capital
Morgan Stanley
Two Sigma Investments

View all funds holding Seres Therapeutics